Gross revenue rose 15.1% to R$41.8B in 2024, with digital sales up 41.7% and market share at 16.5%. Adjusted EBITDA grew 15.0% to R$3.0B, and 2025 guidance targets 330-350 new pharmacy openings.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.